177 Lu-PSMA-617 radioligand therapy for biohemically recurrent prostate cancer
Log in to contact
Tabs
Speciality:
Radiotherapy
Keywords:
lutetium radiotracer-labeled prostate membrane specific antigen radioligand therapy, comparative study, cross-over design